Clinical trial
Improving Obsessive-compulsive Disorder Treatments: From Lesions to Neuromodulation Targets
NCT06490965 is registered in ClinicalTrials.gov with Fundacao Champalimaud as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Improving Obsessive-compulsive Disorder Treatments: From Lesions to Neuromodulation Targets
- Lead sponsor
- Fundacao Champalimaud
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- November 7, 2024
- Completion date
- December 31, 2026
- Enrollment
- 32 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.